Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-Florbetaben PET in Subjective Cognitive Decline
NCT03057938Phase 2Withdrawn
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Jul 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of flutemetamol in subjective cognitive decline (SCD), sponsored by Fundació Clínic per a la Recerca Biomèdica. Planned start Jul 2020; status: withdrawn.
02
Drugs
flutemetamol
03
Conditions
subjective cognitive decline (SCD)
Beyond the preview
Go deeper on NCT03057938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03057938.